Legal status in the United States

Is Liraglutide legal?

Read at FDA, DEA and WADAPublished by PepVault

Liraglutide is FDA-approved (Victoza and Saxenda, first in 2010), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.

Liraglutide at a glance

CheckStatus, read Nov 18, 2026
FDA approvalApproved (Victoza, 2010)
CompoundingApproved drug; FDA proposes no 503B listing
DEA scheduleNot controlled
Sport (WADA)Not named on the list

FDA approval

Liraglutide is FDA-approved, as Victoza in 2010 and as Saxenda in 2014; generic liraglutide injections are approved too.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Liraglutide is the active ingredient of FDA-approved drugs. On April 30, 2026 FDA proposed to keep liraglutide off the 503B bulks list, the list outsourcing facilities may compound from, finding “no clinical need.” Being a component of an FDA-approved drug product is one of the three conditions FDA’s page on bulk drug substances gives for 503A.

The source: “finding no clinical need for outsourcing facilities to compound these drugs from bulk substances”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

The 2026 Prohibited List doesn’t name liraglutide or GLP-1 drugs, and S0, the class for unapproved substances, doesn’t reach an approved drug.

What this means and doesn’t

This page reports what the agencies’ own pages said about Liraglutide in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Liraglutide FDA approved?

    Liraglutide is FDA-approved, as Victoza in 2010 and as Saxenda in 2014; generic liraglutide injections are approved too.

  • Is Liraglutide a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Liraglutide banned in sport?

    The 2026 Prohibited List doesn’t name liraglutide or GLP-1 drugs, and S0, the class for unapproved substances, doesn’t reach an approved drug.

  • What does FDA say about compounding Liraglutide?

    Liraglutide is the active ingredient of FDA-approved drugs. On April 30, 2026 FDA proposed to keep liraglutide off the 503B bulks list, the list outsourcing facilities may compound from, finding “no clinical need.” Being a component of an FDA-approved drug product is one of the three conditions FDA’s page on bulk drug substances gives for 503A.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo